Additionally, in the study of tumor prognosis, it was found that USP39 was closely related to the prognosis of patients with hepatocellular carcinoma, pancreatic ductal adenocarcinoma, glioma, neuroblastoma and other malignant tumors. This evidence concerns the gene USP39 and central nervous system cancer.